SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-164790
Filing Date
2012-04-16
Accepted
2012-04-16 17:31:10
Documents
4
Period of Report
2012-05-11
Effectiveness Date
2012-04-16

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT d330905ddef14a.htm DEF 14A 765279
2 GRAPHIC g330905cm1.jpg GRAPHIC 808
3 GRAPHIC g330905g92o25.jpg GRAPHIC 5358
4 GRAPHIC g330905pc_pg02.jpg GRAPHIC 1446
  Complete submission text file 0001193125-12-164790.txt   777264
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 12762136
SIC: 2836 Biological Products, (No Diagnostic Substances)